MedTrace Logo

Prevalence and Clinical Associates of Iron Deficiency in Patients With Atrial Fibrillation

NCT03957187 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 1000

Last updated 2022-03-14

No results posted yet for this study

Summary

To estimate the prevalence of iron deficiency (ID) in patients with atrial fibrillation

Conditions

Interventions

DIAGNOSTIC_TEST

Ferritin, iron and iron binding capacity, high sensitive C-reactive protein (CRP) measurement

Ferritin, iron and iron binding capacity will be measured for evaluation of ID using Cobas c-e and Elecsys. The relation of inflammation to iron deficiency will be evaluated by high sensitive C-reactive protein measurement.

Sponsors & Collaborators

  • Vifor Pharma

    collaborator INDUSTRY

  • Abdi Ibrahim Ilac San. ve Tic A.S.

    collaborator INDUSTRY

  • Koç University

    lead OTHER

Principal Investigators

  • Dilek Ural, Prof. · Koç University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2022-06-30
Completion
2022-08-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03957187 on ClinicalTrials.gov